Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.

Saved in:
Bibliographic Details
Title: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.
Authors: Bissonnette R; Innovaderm Research Inc., 3530 Saint-Laurent Boulevard, Suite 300, Montreal, QC, H2X 2V1, Canada. rbissonnette@innovaderm.com., Albreiki F; Dermatology, Tawam Hospital, Al Ain, United Arab Emirates., Ehst BD; Oregon Medical Research Center, Portland, OR, USA., Al Hammadi A; DermaMed Clinic, Dubai, United Arab Emirates., Schliemann S; Department of Dermatology, University Hospital Jena, Jena, Germany., Yang B; Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou City, Guangdong, China., Zhang J; Department of Dermatology, Peking University People's Hospital, Beijing, China., Bunick CG; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.; Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, USA.
Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 Jan; Vol. 27 (1), pp. 199-202. Date of Electronic Publication: 2025 Sep 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1888
DOI:10.1007/s40257-025-00974-4